Al's Comment:

 This is an exciting trial for people with leptomeningeal tumors,   Most clinical trials exclude patients with leptomeningeal spread because it is hard to treat and usually has a worse outcome than those who do not have leptomeningeal spread.  This trial only accepts these most difficult cases - hopefully to quickly show how good the treatment works. For details and to join go to  and the contact information is at the bottom of that page. 


Disclaimer: Mustang Bio is now a sponsor of the Musella Foundation!

Posted on: 12/21/2020

Mustang Bio and City of Hope Announce Initiation of Phase 1 Clinical Trial of MB-101 (IL13Rα2-specific CAR T cells) to Treat Leptomeningeal Brain Tumors



Click HERE to return to brain tumor news headlines.